Injury or dysfunction of endothelial cells is an important factor in atherogenesis. Impaired endothelium-dependent relaxation in atherosclerotic arteries has been reported in laboratory animals and humans.' Recent evidence indicates that endothelial dysfunction is an early event, which may even precede the development of coronary atherosclerosis. 2 Hypercholesterolaemia is an important cause of coronary artery disease in humans, and raised plasma concentrations of low density lipoproteins (LDL) are associated with accelerated atherogenesis.3 Moreover, hypercholesterolaemia impairs endothelial vasodilator function at a time when no abnormal structural alterations of the arterial wall are present, as assessed by light and electron microscopy in animals fed a high-cholesterol diet4 or as seen in the human forearm circulation.5
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